Don’t look for pricey hepatitis drugs to come down By: MarketWatch January 13, 2015 at 14:32 PM EST If you’re thinking more competitors will bring down the price of expensive hepatitis C drugs, think again. Read More >> Related Stocks: AbbVie CVS Health Corp Enanta Pharmaceutica Gilead Sciences Merck & Co
